Skip to main content

Medicenna Therapeutics Corp.

MDNAF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001807983

No open-market purchases or sales by Medicenna Therapeutics Corp. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Superinvestors holding MDNAF, Q2 2026

See all superinvestors

No superinvestor reported holding MDNAF in Q2 2026.